Top Story

FDA accepts application for new Humira biosimilar

January 16, 2018
In the Journals

Obesity in children with psoriasis contributes to comorbidities

January 11, 2018
Although children with psoriasis are at greater risk for developing various comorbidities than children without psoriasis, obesity is a stronger independent risk factor…
FDA News

FDA approves Xeljanz for adults with psoriatic arthritis

December 15, 2017
The FDA has approved Xeljanz for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate and…
FDA News

FDA approves Ixifi, third Remicade biosimilar

December 14, 2017
The FDA has approved the third biosimilar to infliximab, infliximab-qbtx, for all eligible indications of the biologic product, according to a company press release…
More Headlines »